Individuals suffering from chronic illnesses are supposed to take their medicine consistently, but when a patients forgets to do that, or days are skipped between prescription refills, the results can be severe enough to require…
EU approved the very first NOAC (or novel oral anticoagulant) Xarelto (rivaroxaban) for broad application. With Bayer and Janssen at the helm, Xarelto can now be broadly used for patients suffering from atrial fibrillation (AF)….
There’s a rising concern about the potential association between vaccination and autism. Although this correlation has never been confirmed by sufficient clinical evidence, it is a fact that vaccines are neither completely safe nor completely…
In one of the most unethical moves of the last few years, the pharmaceutical company Turing is ending the race on cancer and AIDS by killing the very patients who used this medication. The drug…
In what is deemed a break through in cardiovascular medicine treatments, the FDA has approved a new drug called Corlanor (ivabradine). Corlanor is designed to reduce hospitalization time caused by the worsening of heart failure…